I picked this book from a linkedin recommendation by a person who was in the jury of the Financial Times awards for the best business book 2025. This book was judged to be the winner of 2025. 

I am familiar with the AI space and also the company Nvidia, even having the opportunity to chat with Jensen Huang once in Stockholm. In spite of working in this domain for the last 8 odd years, the book opened to me so much trivia and details that I was not aware of previously. 

My favourite anecdote was of the Norwegian researcher Fredrik Dahl, who created the first neural network that could beat a human at the game of backgammon. The software was also commercially successful. Fredrik did this in 1994, which is almost 30 years before this AI era as we know it. This led me to sharing this story with my Norwegian friends and having some indirect conversations with Fredrik, who is still researching AI topics in Oslo. 

The author has done a meticulous job of interviewing a great many people and bringing about the nuance to share the story of one of the greatest companies of our time. He brings multiple views and also provides without much technical jargon for a lay person to understand the complexity of technology that is changing the world as we speak. 

I would highly recommend this book to everyone who is linked with the field of AI or even a user of AI. As this technology is the most fundamental technology of our times and this book provides a unique perspective from the mind of builders who have contributed one of the main vehicles (chip) for this revolution to happen! 

The post Book Review- The Thinking Machine appeared first on InnoHEALTH magazine.

The IC Nursing InnovatorFORUM recently conducted a high-impact educational workshop on the Neonatal Resuscitation Program (NRP) at Yashoda Hospital, reinforcing the pivotal role of nursing professionals in improving neonatal outcomes. Hosted by Lt. Col. Radha Rana,Director – Patient Care services, the workshop was delivered by Dr. Deepika Rastogi, a distinguished pediatrician and an experienced educator in newborn care. The program brought together nurses from labor rooms, neonatal and pediatric intensive care units, operation theatres, postnatal wards, and nursing education institutions, reflecting a multidisciplinary commitment to excellence in neonatal care.

Dr. Deepika Rastogi led the sessions with a strong focus on the principles of the Neonatal Resuscitation Program (NRP) 8th Edition, emphasizing the physiological transition of a newborn from fetal to neonatal life. She highlighted that effective breathing is the most critical determinant of a successful transition at birth, with crying serving only as a surrogate marker rather than the primary goal. The sessions reinforced that neonatal resuscitation is not a routine intervention but a targeted, evidence-based response for newborns who fail to breathe adequately.

A central theme of the workshop was the importance of the “Golden Minute,” the first sixty seconds after birth that are crucial for a newborn’s survival and long-term outcomes. Dr. Rastogi explained that essential resuscitation steps providing warmth, drying, positioning the airway, clearing visible secretions, and stimulating breathing must occur simultaneously and efficiently. This approach encouraged nurses to develop rapid assessment skills and clinical readiness, ensuring timely intervention during delivery room emergencies.

The workshop also clearly differentiated neonatal resuscitation from adult and pediatric life support. Dr. Rastogi emphasized that positive pressure ventilation (PPV) is the single most effective lifesaving intervention in neonatal resuscitation, while cardiac compressions are rarely required unless adequate ventilation has failed. By focusing on basic NRP skills, the program empowered nurses to confidently initiate resuscitation while coordinating with physicians for advanced support when needed.

Teamwork and communication were highlighted as essential components of effective neonatal resuscitation. The importance of pre-resuscitation briefing, role allocation, and seamless coordination between labor room and NICU teams was discussed in detail, particularly in high-risk situations such as preterm deliveries and multiple births. This collaborative, teambased approach was presented as a key strategy for reducing errors and improving newborn outcomes.

An evidence-based discussion on umbilical cord management further enriched the workshop. Dr. Rastogi explained the physiological benefits of delayed cord clamping for both term and preterm infants, including improved hemodynamic stability, reduced risk of intraventricular hemorrhage, and better neonatal adaptation. Participants were encouraged to actively engage with obstetric teams to implement delayed cord clamping whenever clinically appropriate.

Overall, the Neonatal Resuscitation Program workshop organized by IC Nursing InnovatorFORUM and hosted at Yashoda Hospital emerged as a significant educational initiative. Through expert guidance from Dr. Deepika Rastogi and strong nursing leadership, the program underscored the vital role of skilled, confident nurses in saving newborn lives and advancing the quality of maternal and child healthcare.

The post 3rd IC Nursing InnovatorFORUM Meet appeared first on InnoHEALTH magazine.

Nobody asks what happens between pandemics. We obsess over the ones that make headlines, the paralysing fear of a novel virus, the scramble for vaccines, the grief. But quietly, beneath all of that, there is a question epidemiologists lose sleep over: why do outbreaks seem to arrive in clusters? Why does one outbreak’s smoke barely clear before the next fire is set?

In May 2026, the WHO declared the ongoing Ebola outbreak in the Democratic Republic of the Congo and Uganda a Public Health Emergency of International Concern, citing rising cases, cross-border spread, and uncertainties around the epidemic’s scale. At the same time, public health authorities are investigating a cluster of Hantavirus (Andes virus) cases linked to cruise ship passengers.

And this is not new. Outbreaks rarely emerge in isolation. Mpox appeared while COVID-19 was still reshaping societies. Ebola resurged while the world was still counting pandemic losses. For anyone paying attention, there is a structural pattern here; something the world has been building toward for decades.

The Infrastructure of Spillover

Most dangerous emerging viruses do not appear from nowhere. They come from animals, through zoonotic transmission, when pathogens cross from animals to humans. Ebola, Hantavirus, Nipah, SARS, and COVID-19 all emerged through spillover events, where a pathogen adapted to one species found an unexpected doorway into ours.

Over the past century, several interconnected forces have increased the likelihood of pandemics:

• Increased global travel and interconnectedness
• Rapid urbanisation
• Changes in land use
• Expansion into natural ecosystems
• Intensive livestock farming and wildlife exploitation

Every road cut through a forest, every wet market, every expansion of human activity into wildlife habitats becomes a negotiation with the natural world.

Spillover risks are not evenly distributed. Higher-risk regions include:

• China
• India
• West and Central Africa
• The Amazon Basin

Key drivers include:

• Bushmeat hunting and animal-based traditional medicine practices
• Logging and natural resource extraction
• Expansion of roads into wildlife habitats
• High levels of biodiversity and animal-human interaction

When outbreaks appear in compressed timeframes, we are often witnessing the consequences of decades of encroachment, movement, and population density coming due all at once.

Spark and Spread: Two Levers, One Fire

Epidemiologists often think about outbreak risk through two lenses: spark risk and spread risk. Pandemic risk is shaped by both where a disease is likely to emerge and how easily it can move through human populations.

Spark risk is about proximity: how often humans come into contact with animal reservoirs carrying novel pathogens. Spread risk begins after that first contact, and this is where modern life becomes a liability.

Several factors amplify the spread:

• Dense urban populations and overcrowded settlements
• Social inequality and poverty, which increase vulnerability
• Global travel and interconnected transport systems

The Hantavirus cluster being investigated illustrates this well. The Andes virus, one of the few hantaviruses with documented human-to-human transmission, appeared on a cruise ship carrying passengers across multiple countries. In such settings, spread risk multiplies rapidly. Pathogens do not need extreme contagiousness to spread globally; they need mobile hosts and delayed detection.

Before the Guidelines, There Is Us

Public health responses are powerful, but they are inherently reactive. The most meaningful window for interruption exists before official guidance arrives.

Reducing outbreak risk often depends on simple measures:

• Limiting contact with disease reservoirs
• Maintaining clean living and working spaces
• Practising hand hygiene
• Seeking healthcare promptly when symptoms appear
• Providing accurate travel and contact histories

These are not dramatic interventions, but they shorten diagnostic delays and strengthen surveillance systems. There are both structural and human explanations for why epidemics appear to occur in clusters. We have spent decades building conditions that favour spillover and spread, but the speed at which outbreaks escalate still depends on behaviours and decisions made long before any emergency declaration.

The post Why Do Outbreaks Keep Arriving Back-to-Back? The Science Behind Viral ChainTransmission appeared first on InnoHEALTH magazine.

In an era where healthcare is rapidly transforming, diagnostics has emerged as far more than a supporting function it has become the foundation of modern medicine. This central theme unfolded in a recent episode of the InnoHealth Magazine Podcast, where host Dr. Soumya Singh engaged in a deep, nuanced conversation with Dr. Shelly Mahajan, Lab Director & Clinical Head – Genomics at Mahajan Imaging & Labs.

The discussion moved beyond innovation buzzwords to examine the real-world impact of genomics, artificial intelligence, standardization, ethics, and most importantly patient trust.

Diagnostics Moves From the Background to the Frontline

For decades, diagnostics functioned quietly in the background of healthcare. Patients rarely interacted with diagnosticians, and lab reports were often viewed as secondary confirmations of a clinician’s judgment. According to Dr. Mahajan, that perception has fundamentally changed.

“Diagnostics is no longer about confirming illness. It is about predicting disease, preventing it, and managing a person’s entire health journey.”

This shift reflects a broader transformation in healthcare itself. Preventive screenings, wellness monitoring, and early risk assessment now rely heavily on diagnostics. Individuals today engage with testing not only when they are sick, but also when they want to stay healthy making diagnostics a part of everyday life rather than episodic care.

Molecular Diagnostics and the Democratization of Precision

One of the most powerful drivers of this change has been molecular diagnostics. What was once considered niche or highly specialized is now increasingly accessible to routine patients. Dr. Mahajan highlighted how PCR and genomic testing have become household terms, especially following the COVID-19 pandemic.

“Today, we can predict susceptibility to disease by testing DNA from a simple blood or saliva sample and that has completely changed how early we can intervene.”

Molecular diagnostics has revolutionized disease detection across oncology, infectious diseases, and autoimmune disorders. The ability to diagnose earlier, predict risk, and tailor treatment plans has pushed healthcare closer to the ideal of personalized medicine—where therapy is shaped around the individual rather than the average patient.

Artificial Intelligence: Acceleration With Accountability

Artificial intelligence has emerged as a powerful force within diagnostics, improving efficiency, speed, and accuracy in radiology and pathology. AI-powered tools can now screen pathology slides, assist radiologists in detecting early cancers, and reduce diagnostic delays—particularly in regions with limited access to specialists.

However, Dr. Mahajan was unequivocal in her caution: AI is a tool, not a decision-maker.

“AI can screen faster and reduce errors, but it cannot replace clinical judgment. Without human oversight, even the smartest algorithm can misdiagnose.”

She emphasized that AI systems are only as good as the data on which they are trained. A lack of diversity or quality in training datasets can introduce bias, leading to skewed results that directly impact patient care. Continuous validation, transparency, and regulatory oversight are therefore critical to safe AI adoption.

Standardization: The Backbone of Credibility

One of the most pressing concerns raised in the conversation was the lack of uniformity across diagnostic laboratories. Variations in reference ranges, methodologies, and reporting standards often leave patients confused and clinicians uncertain.

Dr. Mahajan stressed that accreditation, adherence to international quality standards, regular audits, calibrated equipment, and continuous staff training are not optional—they are fundamental. Without standardization, diagnostics risks becoming volume-driven rather than value-driven, leading to over-testing, patient anxiety, and unnecessary healthcare costs.

Over-Testing and the Need for Value-Based Diagnostics

While access to diagnostics has improved, it has also created a paradox: more testing does not always mean better care. Over-testing can result in false positives, misdiagnosis, and emotional distress for patients.

Dr. Mahajan advocated for stronger collaboration between clinicians and diagnosticians, evidence-based testing protocols, and better patient education. The goal, she explained, is smarter diagnostics, not more diagnostics.

“We need to move away from volume-based diagnosis and focus on tests that actually add value to a patient’s treatment journey.”

Transparency, Ethics, and Rebuilding Patient Trust

Addressing recent controversies around lab practices and data integrity, Dr. Mahajan underscored that trust is fragile—and once lost, difficult to rebuild. Transparency, she argued, is the most powerful tool laboratories have.

She noted a positive cultural shift: patients now actively want to speak with diagnosticians, discuss reports, and understand their health data. This growing engagement reflects a new era where patients expect not just accuracy, but accountability and empathy.

The Road Ahead: Technology With a Human Core

Looking forward, Dr. Mahajan expressed optimism about emerging breakthroughs such as multi-omics diagnostics, AI-assisted tools for rural healthcare, and continuous monitoring through wearables. These innovations promise earlier detection, ultra-personalized treatment, and improved access.

Yet the podcast made one truth abundantly clear: technology alone cannot define the future of diagnostics.

The future will belong to systems that combine scientific excellence, ethical practice, rigorous quality standards, and human judgment—where every report carries not just data, but responsibility.

As this episode of the InnoHealth Magazine Podcast demonstrates, diagnostics is no longer just about tests. It is about trust, transparency, and putting patients at the heart of innovation. 

The post Diagnostics at the Frontline of Modern Healthcare: From Disease Detection to Prevention appeared first on InnoHEALTH magazine.

With advances in modern medicine and healthcare, human life expectancy has increased dramatically. Today, many chronic diseases, such as diabetes, hypertension, chronic kidney disease, paralysis, osteoporosis, Parkinson’s disease, thalassemia, and even early stage of cancers can be managed with medication. As a result, aging populations are growing worldwide. This demographic shift raises important questions about long-term care options for seniors. Some elderly individuals with chronic diseases opt to live in nursing homes due to their inability to perform self-care and lack of family support. However, others prefer to stay with their children. 

Children living with elderly parents who have chronic diseases face new life challenges, particularly as these parents become dependent on daily activities support. Such caregivers need to juggle personal lives, careers, child-rearing, and parental care responsibilities. Nevertheless, a few important, practical strategies can support and sustain the well-being of both elderly parents and their caregivers.

Practical Tips for Caregiving

Managing elderly parents with chronic diseases is an ongoing process. Developing practical strategies is crucial to sustain caregiving efforts and prevent caregiver burnout.

1. Ensure Medication Compliance for elderly parents

While some elderly parents manage medications independently, others need assistance. Small print on pill labels often makes it hard for them to read dosages or expiry dates, so adding larger, clearer labels can help. Many are also forgetful and can benefit from pre-prepared daily medication organizers. Proper medication adherence is vital, as it helps prevent serious complications. For example, good glucose and blood pressure control prevents or reduces giddiness, and therefore lowers the risk of falls in the elderly.

2. Ensure adequate food and water consumption for elderly parents

Adequate food and water intake is vital for elderly well-being, as malnutrition is prevalent in this group. The World Health Organization (WHO) tackles this through guidelines like screening via BMI and providing tailored nutrition rich in protein, calories, vitamins, and minerals (Rudnicka E 2020).

Common Causes

Malnutrition often stems from factors like ill-fitting dentures, reduced appetite, limited food access, or inconvenience in obtaining supplies. Addressing these by ensuring proper dentures, consistent access to nutrient-dense foods (high in protein, vitamins, minerals, and calories), can effectively mitigate the issue.

Practical Tips

Variety of foods with appealing colors, small but frequent meals, and having meals with them could enhance appetite and food intake. Incorporating light exercise is another way to stimulate hunger that further supports nutritional balance. 

 3. Assist them with exercise to improve muscle tone

As we age, muscles gradually degenerate due inadequate protein intake and insufficient exercise. This process is subtle, progressive and often unnoticed. Without consistent strength training, adults can lose 3% to 8% of muscle mass per decade ((Volpi E 2004). Over time, this sarcopenia hinders daily activities like rising from bed, walking, bathing, and dressing. It also raises risks of falls, bone fractures, and even death.

Therefore, daily strength training is important and essential. It increases endurance for daily self-care activities, preserve mobility, and enhances overall well-being (Tøien T, 2025). Exercises are tailored to fitness level:

• Extremely weak (bedbound >50% of time): Use resistance bands for leg muscles and hand weights for grip strength.
• Moderately weak: Try bed pedal exercises, seated steppers, or recumbent bikes.
• Mobile elderly: Incorporate daily walks, plus gym equipment or fitness tools.

4. Support elderly parents in slowing down age-related memory loss

Memory loss is a common part of aging. Our brain cells gradually decline with age, and inactivity can speed up cognitive decline. The effects of dementia should not be underestimated, they can lead to inability to perform daily activities; in more severe cases, it can lead to forgetting family members or losing one’s way home.

Fortunately, simple lifestyle changes can help to slow this process. Research has shown that engaging the brain through social interaction, or physical activities preserve our cognitive function.

• Social interaction: Talking to elderly parents can help stimulate their memory and enhance their emotional health. We can chat with them about their day, share meals or go for walks together. A previous study, Rush Memory and Aging project, reported that a strong social ties to a 50% lower dementia risk (Wallace 2019).

• Challenge the mind: Solving Sudoku, reading newspapers or magazines, tackling crossword puzzles, and playing chess or cards promote cognitive reserve. Studies have shown that these activities reduce the risk of dementia compared to passive activities (Weziak-Bialowolska, D.,2023) (Werneck 2026).

• Avoid unhelpful habits: In contract, passive activities such as watching TV or scrolling social media offers little cognitive benefit and should be minimized. These activities may even harm brain health if excessive, per findings from the Journal of integrative neuroscience (Manwell,2022).

Self-Care Tips for Caregivers

1. Get enough rest 

Caregiving is physically demanding. The caregivers are constantly on the move to provide for their parents’ needs, such as medication, meals, exercise and companionship. The task becomes even more difficult when the parent falls ill. The responsibilities may also require the caregiver to learn new skills to meet the changing needs. As caregiving is exhausting and time-consuming, it is important for the caregivers to get enough rest and sleep. This will help them recharge and stay physically and emotionally strong to continue providing good care.

2. Sharing responsibility with other siblings

Sharing caregiving tasks with other siblings is a good way to make caregiving more sustainable. When the responsibility is shared, each caregiver can take time off to rest and then return to their role refreshed, like “walking further” without burning out. 

Taking care of elderly parents over the long-term may seem overwhelming and exhausting. However, there are several key aspects of caregiving that we should emphasize to enable effective care and lighten the caregiving burden. Caregivers should also practice good self-care habits to protect their own well-being.

The post Practical Tips for Long-Term Caregivers of Elderly Parents appeared first on InnoHEALTH magazine.

Hantavirus remains one of the most overlooked zoonotic threats today, rare enough to escape sustained public attention yet severe enough to cause alarm when outbreaks occur. With high case fatality rates and persistent animal reservoirs, it continues to expose gaps in global infectious disease preparedness.

What Hantavirus Is, and How It Spreads

Hantaviruses are single-stranded RNA viruses carried primarily by rodents, with each strain usually linked to a specific host species. Humans are typically infected through environmental exposure, not bites.

Transmission can occur through:

• inhalation of aerosolised particles from rodent urine, saliva, or faeces
• contact with contaminated surfaces
• rarely, person-to-person spread

Hantaviruses cause two major syndromes:

• Hantavirus Pulmonary Syndrome (HPS), seen mainly in the Americas
• Hemorrhagic Fever with Renal Syndrome (HFRS), more common in Europe and Asia

More than 20 hantavirus strains are known to infect humans. The current outbreak strain, the Andes virus, is particularly concerning because it is the only known hantavirus capable of human-to-human transmission.

Why Hantavirus Is Difficult to Detect, and Dangerous to Miss

The biggest challenge with hantavirus is timing. Early symptoms often resemble routine viral illnesses, while severe respiratory complications may appear only 4 to 10 days later, rapidly progressing to respiratory failure and shock.

The current outbreak reflected this clearly. The first reported patient developed symptoms on April 6 and died within five days. Hantavirus was only suspected after additional cases emerged, by which time passengers had already travelled across multiple ports.

Three major gaps continue to complicate hantavirus management:

1. Delayed Detection

• No routine hantavirus screening exists in most port health or travel medicine systems
• Awareness remains limited outside endemic regions
• Early cases are often mistaken for influenza or other respiratory infections

2. Limited Treatment Options

• There are currently no globally licensed vaccines or antivirals for hantavirus
• Treatment is largely supportive and dependent on rapid ICU access
• Investigational therapies such as ribavirin, favipiravir, and lactoferrin remain under study

3. Fragmented Surveillance

• Rodent population monitoring is rarely integrated into public health warning systems
• Most outbreak responses remain reactive rather than predictive

Hantavirus outbreaks are not defined only by viral severity but also by how easily the disease can remain invisible during its earliest stages.

The Innovation Imperative

The technology needed to improve hantavirus detection already exists. The challenge is deployment.

Recent real-time RT-qPCR assays can detect hantavirus with sensitivity above 92% and specificity reaching 100%. A dual RT-qPCR system developed in 2025 can even differentiate hantavirus from other febrile illnesses with similar presentations, exactly the kind of tool that could have identified the MV Hondius cases earlier.

What is still missing:

• portable point-of-care diagnostics
• integration into port health and travel medicine systems
• rapid deployment in field settings

Genomic surveillance has advanced rapidly as well. Next-generation sequencing can now:

• track viral evolution
• identify emerging strains
• map transmission chains in real time

Yet most countries still lack a coordinated One Health surveillance framework linking human, animal, and environmental health data.

The vaccine gap is equally striking.

Since 2023, Korea University Vaccine Innovation Centre and Moderna have been developing an mRNA-based hantavirus vaccine. Experimental studies have shown protection in animal models, but as of April 2026, human clinical trials remain delayed due to funding limitations.

The contrast is difficult to ignore:

• the mRNA platform transformed pandemic vaccine development within years
• yet promising hantavirus candidates remain stalled despite high fatality rates in severe infections

In response to the current outbreak, the World Health Organisation deployed field experts and distributed diagnostic kits across multiple countries.

Outbreak response alone is not enough; health systems must be able to detect and contain threats before they spread across borders.

The Larger Lesson

Hantavirus is more than an isolated outbreak. It reflects the growing challenge of zoonotic diseases emerging alongside environmental disruption, global mobility, and expanding human-wildlife contact. Pop

The reservoir will persist, whether in Patagonia, Central Asia, or Southeast Asia. The real question is whether future outbreaks are detected early enough to stop transmission before they spread across borders.

That challenge is no longer scientific alone. It is a question of preparedness, investment, and public health prioritisation.

The post Hantavirus Outbreak 2026: Why Early Detection and Preparedness Still Matter appeared first on InnoHEALTH magazine.

A Home Built of Courage and Chlorhexidine

Harsh’s illness began with a cough and a chill that burrowed into his bones. A hazy patch on the X-ray revealed pneumonia, and the plan sounded simple: IV antibiotics, oxygen, fluids. 

“Every pill felt like a promise, but the fever kept laughing at us.”

On 3^rd day, he was in the ICU. The team moved stepwise through therapy – first-line antibiotics, then second-line combinations of antibiotics, and finally last-resort antibiotics that were not only expensive but also toxic. Blood cultures returned with words that closed the air in the room: resistant to usual antibiotics; resistant to broader combinations.

His breathing grew heavier, blood pressure dipped, and ventilatory support kept him afloat. Days turned into tallies -day 7 of fever, day 10 of oxygen masks, day 13 and then day 20 of antibiotics that failed in journals and were failing in him. The family faced decisions no one wants to make: intubate again or not, resuscitate or allow a natural end.

“He said, ‘Take me home,’ and we stood frozen. Every choice felt like betrayal – hope on one side, his wish on the other.”

In that instant, the hospital walls felt heavier than hope, and the family realized care was no longer about medicine alone—it was about dignity and the family’s world shifted from hospital corridors to the fragile hope of home care.  Love built a hospital room at home -rails on the bed, oxygen cylinders, suction, sterile dressing kits, and nurses on every shift. Medicines arrived in brown bags; lab reports spoke in arrows and forecasts of storm after storm. Savings thinned to bone and yet hope endured.

“I’m not afraid. I’m tired. Let me go” –  Harsh, to his family one night as monitors traced his heartbeats like a small bird.

Two months passed like a long winter with no gap in the cloud. One night, numbers softened and slid away. Later, Meera, his wife, paused over a lab report and the term that had shadowed them: multidrug resistant. ‘These words didn’t exist when we were children,’ she told her daughter. ‘Now they follow us everywhere.’ 

From a Family Member: “We thought antibiotics were magic. No one told us they could fail.”

Another Family’s Loss

A tearful daughter laments, “the diagnosis of cancer was daunting for us, but the reassurance from the doctor that it is curable gave us hope. My mother was admitted for her first chemotherapy, but suddenly her condition worsened. The doctor informed them that she had acquired an infection and reassured us that she has been started on antibiotics and would soon recover. However, days turned to weeks, but the fever failed to abate. The hospital tried all possible antibiotics, but the superbug won; and we lost her not to cancer but to a bug! We never imagined a tiny germ could defeat every medicine the doctors had.

“We kept asking, isn’t there one more antibiotic? But the answer was silence.”

Another story: The Battle That Almost Broke Us

Ravi was admitted with a raging infection that spiraled out of control. Doctors escalated from first-line antibiotics to last-resort drugs. His blood pressure dipped; breathing faltered; consent forms piled up.

After weeks of ventilators and toxic medications, the fever finally broke and the tubes came out. He returned home but the question that haunts his family remains: what if those medicines hadn’t worked?

From a Caregiver:

“Watching the monitors dip while waiting for an antibiotic to work is a kind of helplessness you can’t describe.”

From a Survivor:

“I walked out of the ICU, but the fear stayed – what if next time, there’s nothing left to try?”

AMR: A Quiet Emergency in Every Home

This is the landscape of antimicrobial resistance (AMR): where therapies we rely on no longer work and the distance between infection and cure keeps widening.

AMR does not spread like a virus, but grows in every ward, every prescription, and every community. First-line treatments fail; second-line options buckle; even last-resort medications offer only brief, deceptive pauses before fever rises again.

AMR: A Natural Phenomenon Accelerated by Human Actions

AMR begins as a natural biological process – microbes adapt to survive. Bacteria have always evolved defence mechanisms against threats, including antibiotics. However, this phenomenon is accelerated by human behaviour, especially the overuse and misuse of antibiotics.

Unlike most medicines, antibiotics are unique: their impact is not confined to the individual taking them. Every unnecessary dose or incomplete course creates selective pressure, enabling resistant bacteria to thrive and spread. This means one person’s misuse can affect an entire community, turning what should be a personal treatment into a public health challenge.

The causes are embedded in our practices: antibiotics taken without prescriptions, courses stopped midway to save money, overcrowded hospitals where bacteria trade survival tactics, and environmental contamination from pharmaceutical waste.

The Fragile Lifeline: Why We Rely on Last-Resort Drugs

Compounding the crisis, the pipeline for new antibiotics is running dry. Development of new antibiotics is slow, expensive, and often unprofitable, leaving us with last-resort antibiotics that cost more than a month’s salary and sometimes even more and offer only temporary reprieve.  Until now, new antibiotics have managed to keep pace with evolving resistance, but in the future, we may not have that safety net as the pipeline continues to shrink. This makes it critical to preserve the precious resources we have today – losing antibiotics would mean gambling on the hope that future science will rescue us from infections that could otherwise be prevented or treated now.

Solutions Are Within Reach

Prevention and stewardship cost far less than escalation and failure. Hand hygiene, rational prescribing, and informed conversations can change the course of care. Stewardship must become a culture, not just a protocol.

Together, these steps form a safety net – one that protects not just individual patients but entire health systems from the silent pandemic of antimicrobial resistance.

A Bell That Rings for Change

Harsh’s bell still hangs above the television. Once, it marked victory over cancer; now it calls for accountability and hope. His story deserves more than sorrow – it deserves a promise that the next family will not watch antibiotics fail, one after another.

Meera volunteers with a patient group, urging families to preserve the power of life-saving antibiotics avoid self-medication, sharing of drugs, and demanding antibiotics unnecessarily. Let the next bell ring for recovery, not remembrance.

The post The Fever That Wouldn’t Break: When antibiotics fail, hope becomes the last medicine appeared first on InnoHEALTH magazine.

What if the next big war didn’t start with tanks or missiles but with a cough?

Sounds like science fiction, right? But this is exactly what makes bioterrorism such a frightening idea. It’s the use of viruses, bacteria, or toxins by people or groups to cause harm, chaos, or even mass death. And the scariest part? It’s nearly invisible until it’s already too late.

As our technology advances and pandemics like COVID-19 show us how fragile our world can be, the idea of bioterrorism has gone from something you see in movies to something experts are seriously warning us about.

A look back: Bioterrorism isn’t new

While the word bioterrorism might sound modern, using disease as a weapon has been happening for centuries.

• Back in 1346, during the siege of a city called Caffa, Mongol forces reportedly threw plague-infected bodies over the walls to spread disease. That might have even helped spark the Black Death in Europe.
• In World War II, Japan’s infamous Unit 731 experimented on prisoners and released deadly bacteria like anthrax and plague in China.
• Fast forward to 1984, a religious cult in Oregon poisoned salad bars with salmonella to try to rig an election. Over 750 people got sick.
• Then there were the 2001 anthrax letters in the U.S., where powdered anthrax spores were sent through the mail to journalists and senators. Five people died, and the whole country was on edge.

So no, this isn’t just a modern or movie-inspired threat it’s something that’s happened before.

Why Bioterrorism could be the next big threat

We’re living in a time where almost anyone can learn anything online. Combine that with powerful new biotech tools, and you start to see why experts are worried.

Here’s what makes the threat real:

• CRISPR and gene editing let scientists (or bad actors) twist  viruses or even build new ones.
• Biological equipment that used to only exist in government labs is now available for purchase online.
• Delivery methods have gotten sneakier think drones, air vents, or even contaminated food.

Unlike nuclear weapons, biological weapons don’t need millions of dollars or rare materials. They can be small, cheap, and very, very effective especially if no one sees them coming.

Was COVID-19 a Bioterrorism attack?

Let’s talk about the elephant in the room.

Since COVID-19 rocked the world in 2020, people have wondered: was it just a natural pandemic or was it something more sinister?

Here’s what we know so far:

• Most scientists believe it came from animals probably bats through a process called zoonotic spillover.
• Some researchers and governments are still investigating the idea of a lab leak, but that’s very different from a deliberate attack.
• There’s no real evidence that COVID-19 was a planned bioterrorist act.

But the fact that this question even exists shows how scared people are and how unprepared we were.

The Dark Web: where dangerous ideas can spread

The dark web is like the hidden underbelly of the internet places you can’t find through Google. And yes, it’s as shady as it sounds.

People have reported finding:

• Black market listings for biological agents like ricin or anthrax (though many turn out to be scams or law enforcement traps).
• DIY guides on how to make biological weapons.
• Online spaces where extremists look for people with biology skills.

Even if most of it isn’t real or usable, it shows just how low the barrier could be for someone determined enough to try.

What can we do about it?

This isn’t about fear—it’s about being ready. Here’s how we start:

1. Stronger Global Rules

We need better international agreements and more vigilant on undisclosed research especially when it could be used to create harmful viruses.

2. Better Early Warning Systems

We need to be able to spot and respond to outbreaks faster, with good diagnostics, rapid vaccine development, and global cooperation.

3. More Public Awareness

People working in labs need to understand the risks of dual-use science in the field of research that could help or harm humanity depending on its use.

4. Watch the Digital Space

Governments and cybersecurity teams should monitor the dark web for early signs of bioterror plots, just like they do for cyberattacks.

Final Thoughts: Are we ready?

Bioterrorism isn’t just about scary viruses or high-tech labs,it’s about how connected and vulnerable we’ve become. COVID-19 wasn’t an act of war, but it taught us a hard lesson: invisible threats can shut down the world faster than any army.

This doesn’t mean we should panic. It means we should be smart, stay informed, and take real steps to prepare for a future where the next big threat might come from a petri dish, not a battlefield.

The best weapon we have? Awareness and Action.

The post Bioterrorism: Unplanned Invisible War Have you ever thought about a war without bombs?  appeared first on InnoHEALTH magazine.

The Ayushman Bharat Evolution: From Targeted to Universal

The Original Vision and Its Limitations

When Ayushman Bharat PM-JAY was launched in 2018, it represented the world’s largest health insurance scheme, covering 10.74 crore families with ₹5 lakh annual coverage. The scheme’s socio economic targeting mechanism, based on the Socio-Economic Caste Census (SECC) 2011 data, aimed to identify the most vulnerable populations. However, this approach created artificial boundaries that excluded many middle-class families who couldn’t afford private healthcare but didn’t qualify for government assistance.

The scheme’s implementation revealed both strengths and weaknesses. On the positive side, it created a vast network of empaneled hospitals, established standardized treatment protocols, and introduced digital infrastructure for claim processing. The National Health Authority’s data shows that over 5 crore treatments have been authorized under PM-JAY, with a total claim value exceeding ₹70,000 crores.
However, the limitations were equally apparent. Rural areas struggled with hospital availability, with many districts having fewer than five empaneled facilities. The scheme’s focus on secondary and tertiary care, while necessary, didn’t address the primary healthcare gaps that prevented early intervention. Most critically, the income-based eligibility criteria created a coverage cliff—families just above the poverty line found themselves in a healthcare no-man’s land.

The Vaya Vandana Paradigm Shift

The Ayushman Vaya Vandana Card addresses these limitations through a fundamentally different approach. By providing universal coverage to all citizens above 70, regardless of economic status, it acknowledges that healthcare needs transcend socio-economic boundaries, particularly for vulnerable populations like the elderly. This shift is demographically prescient. India’s elderly population (60+) is projected to grow from 104 million in 2011 to 319 million by 2050. The 70+ demographic, currently around 50 million, faces the highest healthcare costs due to multiple chronic conditions, frequent
hospitalizations, and complex treatment requirements. The scheme’s universal approach eliminates the bureaucratic hurdles and social stigma often associated with means-tested programs. The rapid enrollment—over 28,000 in Delhi within a week—demonstrates pent-up demand. More significantly, it reveals the inadequacy of existing coverage mechanisms. If middle-class seniors are rushing to enroll in a government scheme, it indicates that private insurance and out-of-pocket payments have failed to provide adequate financial protection.

The Financing Crisis: Numbers Don’t Lie

The Expenditure Gap

India’s healthcare financing presents a sobering picture that no amount of political rhetoric can obscure. At 1.3% of GDP, our public health expenditure ranks among the lowest globally. To put this in perspective, countries with successful universal health systems spend significantly more: the UK (7.5%), France (8.1%), Germany (9.4%), and even middle-income countries like Thailand (2.7%) and Brazil (4.2%).

This chronic underfunding manifests in multiple ways. The per capita public health expenditure in India is approximately $19, compared to $3,000 in developed nations and $75-150 in comparable middle-income countries. Even accounting for purchasing power parity, the gap remains substantial. The Fifteenth Finance Commission’s recommendation to increase public health expenditure to 2.5% of GDP by 2025 represents progress, but even this target falls short of what’s needed for universal coverage. Health economists estimate that achieving comprehensive universal health coverage would require 3-4% of GDP in public spending, implying a tripling of current expenditure levels.

The Out-of-Pocket Burden

Perhaps more troubling is India’s reliance on out-of-pocket expenditure, which accounts for nearly 65% of total health spending—among the highest globally. This means that most healthcare costs are borne directly by families, often leading to catastrophic expenditure and
medical bankruptcy. The National Sample Survey Office (NSSO) data reveals that healthcare expenses push approximately 7% of the population below the poverty line annually. In rural areas, nearly 24% of hospitalization cases result in catastrophic expenditure (exceeding 10% of household consumption), while in urban areas, the figure is 18%. This financial burden disproportionately affects vulnerable populations. Scheduled Castes and Scheduled Tribes face higher out-of-pocket payments relative to their income levels. Women often delay or forgo treatment due to financial constraints and social prioritization of male family members’ health needs.

Insurance Coverage Gaps

Despite the expansion of health insurance through various schemes, coverage remains inadequate and fragmented. The National Family Health Survey-5 (2019-21) shows that only 41% of households have any health insurance or financial protection for health. Even among covered populations, the depth of coverage is often insufficient. Private health insurance, while growing, covers only 17% of the population, primarily urban, educated, and affluent segments. Premium increases of 15-20% annually make private insurance increasingly unaffordable for middle-class families. Moreover, private policies often exclude pre-existing conditions, impose waiting periods, and limit coverage for chronic diseases precisely the areas where coverage is most needed.

Infrastructure Deficits: The Ground Reality

Healthcare Facility Shortages

India’s healthcare infrastructure reveals stark inadequacies that undermine policy ambitions. The country has approximately 0.7 hospital beds per 1,000 population, significantly below the WHO recommendation of 3-5 beds. This translates to a shortage of over 2 million hospital beds nationally. In the state capital, state-owned healthcare facilities are actively addressing a staff shortage challenge. At King George’s Medical University (KGMU), there are currently 712 out of 1,230 sanctioned positions that need to be filled. This situation arises despite the state approving an additional 525 doctor positions last year, bringing the total number of posts to 718. According to KGMU spokesperson Dr. KK Singh, “Until last year, only 187 of the sanctioned positions were vacant. The state government has taken a positive step by approving 525 more professor positions for KGMU, and we are now working on recruitment drives to fill these roles effectively.”

At Balrampur Hospital, 34 out of 104 doctor positions are currently vacant, and at Lok Bandhu Hospital, there are 15 out of 88 sanctioned positions available. This information, shared by hospital officials under the condition of anonymity, highlights the ongoing efforts to enhance staffing and improve healthcare services in the region. With focused recruitment initiatives, there is potential for significant progress in addressing these vacancies and strengthening the healthcare workforce.

Quality Standards Crisis

“Ramesh, a 32-year-old construction worker, first visited his local clinic when he was having a persistent cough that refused to go away. For over two months, he had been suffering from coughing, recurring fever, and unexplained weight loss. The classic symptoms that should have raised red flags for tuberculosis (TB). But due to limited infrastructure and inadequate diagnostic support, his condition was misread as simple bronchitis. The technician, lacking proper training and resources, failed to spot early signs of TB. The doctor, relying on this flawed report, prescribed a general course of antibiotics and sent Ramesh home. Two more painful months passed. Ramesh’s condition worsened. His cough began producing blood, and severe fatigue left him unable to work. “

This story highlights a significant systemic failure in our country. Low-quality diagnostic services, often caused by under-resourced facilities, a lack of quality checks, and insufficient training, result in misdiagnosis, delayed treatment, worsening health, and increased healthcare costs.

According to the National Health Profile 2023, only 12% of primary health centers (PHCs) in India have diagnostic laboratories, and many of these do not meet even basic quality standards. This creates a significant diagnostic gap in rural areas, causing patients to turn to unregulated and

low-quality private labs. The consequences are severe: delayed or missed diagnoses, prolonged illness, high out-of-pocket expenses, and ultimately, preventable deaths. While decentralized diagnostics are essential, India must also invest in national reference laboratories to support complex testing and surveillance. Establishing 50 NABL-accredited reference labs, each serving approximately 25 million people, would provide comprehensive national coverage. These centers should be equipped with AI-assisted digital microscopy, real-time PCR machines, and cloud-based data systems for seamless integration into the healthcare system.

Public-private partnerships can be utilized to train laboratory personnel at these reference centers, ensuring they acquire both theoretical knowledge and practical skills. The curriculum should focus on AI tools, quality protocols, and patient-centered diagnostic delivery. Diagnostics are not merely support tools; they are central to effective healthcare delivery. Without timely and accurate testing, even the best clinical decisions can fail. As India aims for Universal Health Coverage and a $5 trillion economy, strengthening diagnostic services, especially at the grassroots level, is not optional; it is an urgent public health imperative.

Governance Challenges: The Coordination Crisis

The Federal Tug-of-War

Lately, the central government has been stepping up its role in healthcare, and there are a few reasons for this shift. One key reason is the growing significance of global public health, which is reshaping the relationship between central and state governments. Over the past ten years, we’ve seen a significant expansion in international public health standards. The World Health Organization (WHO) has introduced crucial guidelines for its member countries regarding disease tracking and responses to health threats. Often, these global regulations prioritize health emergencies, such as pandemics, over national sovereignty, which means that countries have to fulfill these international commitments.

In many federal nations, including India, governments have leveraged these international agreements to establish national health laws. This sometimes curtails the authority of state governments. A prime example is the National Rural Health Mission (NRHM), initiated by the United Progressive Alliance government in 2005. This program was heavily influenced by concepts from organizations like the World Bank and the WHO, which left states with minimal input in its development. Nowadays, the emphasis has shifted towards making districts the focal points for health initiatives, often sidelining state governments in the process of tackling coordination challenges.

The second major shift in Health federalism is currently experiencing a significant transformation, largely driven by rapid technological advancements, particularly the ongoing data revolution that utilizes data clouds transcending physical borders. This surge in health data from diverse sources necessitates centralized management to facilitate effective policymaking, which in turn impacts local autonomy.

Take, for instance, the federal government’s National Digital Health Blueprint (NDHB), which is working towards establishing an integrated health information system. The goal here is to enhance transparency, boost efficiency, and elevate the quality of care for citizens. While the NDHB is managed at the federal level and aims to collaborate effectively with both public and private entities, it unfortunately lacks the active participation of state governments.

In conclusion, the emergence of digital technology and the data revolution in healthcare are having a profound effect on health federalism. The third and most significant shift in health federalism has been triggered by the impact of the COVID-19 pandemic has changed the game when it comes to health federalism. The rapid spread of the virus pushed the Central government to act swiftly. With no clear laws in place to handle the crisis, they turned to emergency powers granted by the Disaster Management Act of 2005. This gave them the authority to enforce national lockdowns and quickly roll out measures for producing, purchasing, pricing, and distributing vaccines to help control the outbreak.

While these actions were crucial, they did impact the dynamic between the Centre and the states. As the pandemic dragged on, many states, particularly those led by opposition parties, accused the federal government of overreaching and infringing on their rights regarding health service delivery.

Moreover, the challenges in coordination between the Centre and the states during this time have prompted some experts and policymakers to advocate for reforms. They argue that the shortcomings revealed in the Indian federal system during the pandemic should lead to health being moved to the “Concurrent List.” This shift would empower the federal government to take a more significant role in health matters, much like it does in education.

Global Lessons: Learning from Success and Failure :

The British NHS Model: Universal Access Through Taxation

The National Health Service (NHS) in the UK was set up in 1948 as a groundbreaking initiative to ensure everyone has access to healthcare, funded through taxes. The beauty of the NHS is that it provides free healthcare to anyone who needs it, with a tax system that asks more from those who earn more.

The NHS boasts several advantages. It guarantees healthcare access for all, keeps costs in check, and emphasizes primary care. Thanks to this, the UK enjoys impressive health outcomes, including high life expectancy and low infant mortality rates. Most importantly, healthcare is available to everyone, no matter their financial situation.

That said, the NHS is grappling with significant challenges that could offer valuable insights for India. Ongoing funding struggles have resulted in long wait times for non-urgent surgeries, with some patients waiting over a year. Additionally, the system is feeling the strain from a growing demand due to an aging population and rising healthcare expenses.

For India, the NHS model holds important lessons. First, achieving universal access through taxation is feasible, but it demands strong political backing and adequate funding. Second, a robust primary care system can help minimize expensive hospital visits. Third, while centralized purchasing can help control costs, it might also restrict choices and stifle innovation.

Furthermore, the NHS’s recent emphasis on digital health and integrated care could serve as a roadmap for India’s digital health initiatives. However, the UK’s more uniform population and centralized management make it challenging to directly apply this model in India’s diverse and intricate landscape.

China’s Healthcare Reforms: Scale and Speed

China’s healthcare reforms since 2009 provide a fascinating look at how a large and diverse nation can transform its health system. In just ten years, China managed to achieve nearly universal insurance coverage and significantly boost public health spending.

The strategy focused on expanding insurance coverage, strengthening primary care, and reforming public hospitals. The country poured resources into healthcare infrastructure, building thousands of community health centers and training millions of health workers.

However, these reforms also highlighted some challenges. Even with universal coverage, many people still face high out-of-pocket expenses, and the quality of healthcare can vary widely from one region to another. The system grapples with issues like inefficient resource allocation and misaligned incentives.

For India, China’s journey underscores the need for comprehensive reforms that address financing, delivery, and governance all at once. Simply expanding insurance isn’t enough if the underlying supply-side issues and quality concerns aren’t tackled.

Germany’s Social Insurance Model: Balancing Public and Private

Germany boasts a healthcare system that cleverly blends social insurance with regulated competition. This setup aims to strike a balance between public services and market-driven approaches. Impressively, it covers 99% of the population, with 85% relying on statutory health insurance and the remaining 15% opting for private insurance.

There are plenty of strengths in the German system. It ensures universal coverage, enjoys high patient satisfaction, and effectively manages costs. While there’s competition among various insurance funds, it also fosters solidarity through risk pooling and contributions based on income. This combination contributes to high life expectancy and low mortality rates.

On the flip side, the system can be quite complex. The multitude of insurance funds, intricate regulations, and the mix of public and private options lead to a fair amount of administrative work. Additionally, the system relies heavily on a robust formal economy to gather insurance contributions, which poses a significant challenge for India, given its large informal sector.

India could take a page from Germany’s playbook, particularly in areas like regulated competition and risk pooling. By focusing on preventive care and effectively managing chronic diseases, Germany’s approach could provide valuable insights for India as it grapples with rising health challenges. However, for India to successfully implement social insurance, it would need to formalize its economy and enhance its regulatory frameworks.

Technology as a Game Changer: The Digital Health Revolution :

The Digital Health Mission’s Promise

India’s Ayushman Bharat Digital Mission (ABDM) is a groundbreaking initiative in the realm of digital health. Its goal is to seamlessly connect patients, healthcare providers, and health records into a unified system that spans the entire country.

At the heart of the ABDM are unique health IDs for every citizen, comprehensive lists of healthcare providers, and systems designed to facilitate easy sharing of health information. This approach aims to streamline information exchange, reduce medical errors, and enhance the overall quality of care.

So far, the initial outcomes are promising. Several states have begun issuing health IDs, and pilot projects are demonstrating the system’s potential effectiveness. The mission also emphasizes the importance of data sharing with consent and safeguarding privacy, addressing crucial concerns surrounding digital health systems.

Nonetheless, significant challenges remain. A considerable number of individuals, particularly the elderly and those living in rural areas, struggle with low digital literacy. Additionally, healthcare providers in these rural regions often lack the necessary tools and training to effectively utilize digital systems.

Telemedicine’s Transformative Potential

The COVID-19 pandemic accelerated telemedicine adoption in India, demonstrating its potential to bridge geographic access barriers. The expansion of Tele MANAS to handle over 17.6 lakh mental health calls shows how technology can address specialized care shortages.

Telemedicine offers particular promise for chronic disease management, where regular monitoring and consultation are required but don’t always necessitate physical examination. Diabetes, hypertension, and mental health conditions—major health challenges in India—are well-suited to telemedicine interventions.

However, telemedicine’s effectiveness depends on adequate digital infrastructure, provider training, and patient education. Rural areas often lack reliable internet connectivity, limiting telemedicine’s reach precisely where it’s most needed.

Artificial Intelligence and Diagnostics

AI applications in healthcare offer significant potential for India, particularly in diagnostics and screening. AI-powered screening for diabetic retinopathy, tuberculosis detection in chest X-rays, and automated ECG interpretation can extend specialist expertise to underserved areas.

Several Indian companies and research institutions are developing AI solutions for healthcare. However, most applications remain in pilot stages, and regulatory frameworks for AI in healthcare are still evolving.

The key challenge is ensuring AI applications are validated for Indian populations and healthcare contexts. Most AI algorithms are trained on data from developed countries, potentially limiting their applicability to Indian patients and healthcare settings.

The Way Forward: A Comprehensive Reform Agenda :

Short-term Priorities (1-3 years)

The immediate priority must be strengthening the foundation of India’s healthcare system while building on recent initiatives like Ayushman Vaya Vandana.

Financing Reforms: Increase public health expenditure to 2% of GDP within three years through progressive budget reallocation and new revenue sources. Implement outcome-based budgeting to ensure resources translate into improved health outcomes.

Infrastructure Acceleration: Fast-track the Health and Wellness Center program to establish comprehensive primary care networks. Focus on rural and underserved areas where infrastructure gaps are most acute. Ensure centers are adequately staffed and equipped before declaring them functional.

Human Resource Emergency Response: Implement a national healthcare workforce emergency plan including accelerated training programs, rural service incentives, and improved working conditions in public facilities. Create fast-track licensing for qualified foreign healthcare professionals to address immediate shortages.

Digital Health Foundation: Accelerate ABDM implementation with a focus on interoperability and user experience. Ensure digital systems enhance rather than complicate healthcare delivery. Prioritize rural connectivity and digital literacy programs.

Quality Assurance Systems: Establish mandatory minimum quality standards for all healthcare facilities. Implement systematic patient safety monitoring and medical error reporting systems. Create patient feedback mechanisms to drive continuous improvement.

Medium-term Transformation (3-7 years)

The medium-term focus should be on systemic transformation that addresses root causes rather than symptoms.

Universal Health Coverage Architecture: Design and implement a comprehensive UHC system that integrates existing schemes while expanding coverage to currently excluded populations. Move beyond insurance toward integrated service delivery networks.

Preventive Care Revolution: Shift healthcare focus from curative to preventive care through comprehensive lifestyle intervention programs, community health initiatives, and environmental health improvements. Integrate prevention into all healthcare settings.

Healthcare Workforce Transformation: Restructure medical and nursing education to emphasize primary care, rural service, and community health. Create new cadres of healthcare workers suited to Indian conditions. Implement continuous professional development systems.

Technology Integration: Deploy AI, telemedicine, and digital health tools at scale. Ensure technology augments human capabilities rather than replacing human connection in healthcare. Address digital divides that could exacerbate health inequities.

Governance Strengthening: Establish unified healthcare governance systems that coordinate across levels of government and sectors. Implement performance management systems that reward outcomes rather than outputs.

Long-term Vision (7-15 years)

The long-term vision should position India as a global leader in equitable, efficient, and innovative healthcare delivery.

Health System Maturity: Achieve healthcare system performance comparable to develope countries while maintaining affordability and accessibility. Establish India as a model for other developing countries.

Innovation Leadership: Become a global leader in healthcare innovation, particularly in areas relevant to developing countries. Export Indian healthcare innovations and expertise to other nations.

Health Equity Achievement: Eliminate health disparities based on geography, income, gender, and social status. Ensure that health outcomes depend on individual biology rather than social circumstances.

Sustainable Financing: Establish sustainable healthcare financing that doesn’t depend on out-of- pocket payments or external assistance. Create financing mechanisms that are equitable, efficient, and politically sustainable.

Global Health Contribution: Contribute significantly to global health improvement through research, innovation, and technical assistance. Position India as a responsible global health leader.

Conclusion: The Imperative for Transformation

India is standing at a pivotal moment in its healthcare journey. The introduction of Ayushman Vaya Vandana marks a crucial step towards achieving universal health coverage, yet numerous challenges still lie ahead. The country faces a choice: should it opt for minor enhancements, or fully commit to a transformative overhaul to meet the demands of the 21st century?

The rising demand for healthcare, driven by population growth and economic development, is stretching our current system to its limits. The COVID-19 pandemic has brought this issue to the forefront, and as we look ahead, challenges like potential new pandemics and an aging population will only complicate matters further.

Research indicates that countries that invest early and comprehensively in healthcare tend to achieve better outcomes at lower costs. For instance, Thailand’s swift transition to universal coverage and Rwanda’s rebuilding of its health system post-conflict demonstrate that significant change is achievable with strong political will and effective strategies.

However, implementing change involves making tough choices about how to allocate resources and ensuring ongoing political backing, even when the financial burden is heavy. The alternative—staying stuck in dysfunction—will only lead to more suffering and greater inequalities. The Ayushman Vaya Vandana Card offers a pathway to establishing a universal healthcare system, but simply having insurance isn’t sufficient. We need to tackle issues related to the quality of care, supply chain challenges, and gaps in preventive measures.

India’s healthcare reform must be all-encompassing, addressing financing, infrastructure, workforce, governance, and quality in tandem. Piecemeal reforms could inadvertently create new issues without resolving the core problems. Moreover, the choices India makes will resonate on a global scale. A successful transformation could demonstrate that large developing nations can achieve health equity, while a failure might imply that universal health coverage is still a luxury reserved for wealthier countries. The opportunity for transformation is narrowing. Political cycles limit the chances for reform, and the pandemic has underscored the urgency for swift action.

Ultimately, India must choose between a healthcare system where access depends on location, income, and social status, or one that ensures health as a basic right. The Ayushman Vaya Vandana Card presents the opportunity for bold action, but the key question is whether India will act now to create a healthcare system that reflects its values and goals. India’s healthcare future depends on the choices made today. The chance for real change may not come again soon. We must decide: will India take action now or stick with a failing system? For the sake of future generations, the choice is clear: comprehensive transformation must start now.

The post India’s Healthcare Revolution: Bold Steps Forward, Miles to Go appeared first on InnoHEALTH magazine.

The ability to follow a food product and its ingredients backward and forward across the whole supply chain is known as food traceability. Traceability allows for the tracking and linking of food product and ingredient creation, preparation, and distribution chains. In the case of a contamination event or outbreak of foodborne illness, efficient product tracing allows government agencies, food manufacturers, and distributors to promptly determine the origin of items and the probable areas of contamination.

Consequently, the chance of foodborne infections can be reduced by swiftly removing the hazardous product from the market. Food businesses can avoid business disruption and potential health risks to the public by concentrating on the product or products that are impacted by a food safety concern. Traceability is essential for importers and merchants alike in the food industry.

Foodborne infections such as Ptomaine poisoning and salmonella can serve as examples of food traceability. The interested agencies’ ability to identify the product and its components enables them to comprehend the origin of the contamination and effectively handle it. This suggests that contaminated items can be pulled off the market and withdrawn, which will stop the development of foodborne illness outbreaks. The tracking of food will give you the skills to undertake product recalls and maintain compliance for your firm by enabling you to keep an eye on your perishable inventory. The greatest food traceability systems make it simple for you to locate details regarding the raw ingredients and manufacturing process of your items, whether they are used in a batch or as a single ingredient.

By improving the traceability systems at various facilities, it would also be prudent to encourage peer-to-peer learning, knowledge transmission, and the development of partnerships between large food sectors and medium- and small-sized firms. The regulator should also take the lead in educating and certifying all parties involved in the traceability system’s protocols.

FBOs should use vendor-neutral technologies and open standards that facilitate track and trace throughout food supply chains in order to lower risks and carry out effective product recalls.

A blockchain is a decentralised database that stores data in a way that makes it hard to tamper with or manipulate the system. Food sector businesses need to track and trace their food. Unfortunately, the majority of documentation in agricultural products supply chains is done manually and on paper, which leaves a lot of room for fraud and data manipulation. Problems with the food supply chain become increasingly complicated and difficult to track down, particularly when several nations while system are involved.

A blockchain is a decentralised database that stores data in a way that makes it hard to tamper with or manipulate the system. Businesses are still dependent on stakeholders to provide truthful and accurate information, even when they utilise software. This makes them susceptible to human mistake and record tampering. There isn’t a single, easily available source of information for all parties involved, and numerous actors maintain their own records of transactions. Food contamination is typically caused by these issues.

Food surveillance systems can also aid in enhancing the authenticity and traceability of food items. This is especially crucial in sectors where fraud and mislabelling are prevalent, including the fisheries and meat industries. Food traceability systems serve to verify that consumers are receiving the items they pay for and may contribute to prevent fraud by tracing the distribution of food products along the supply chain. Food traceability systems have a number of advantages for the food sector, but they are not without difficulties. It can be challenging to implement efficient traceability systems, especially for businesses of all sizes (SMEs), which might not have the resources and knowledge required to handle intricate supply chains.

We will look at a few of the major issues surrounding food tracking in supply chains in this part. The intricacy of food supply chains poses a significant obstacle to the successful implementation of traceability systems. Before food goods reach the final customer, they may go through a number of intermediaries, such as manufacturers, processors, distributors, and retailers. This makes it challenging to monitor the flow of food items and pinpoint the cause of any invasion or problems with quality.

The post Food Traceability: A New Way Of Food Security appeared first on InnoHEALTH magazine.